<DOC>
	<DOCNO>NCT02201849</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , pharmacokinetics ALKS 8700 , monomethyl fumerate ( MMF ) molecule .</brief_summary>
	<brief_title>A Study ALKS 8700 , Monomethyl Fumarate ( MMF ) Molecule , Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Has bodymass Index ( BMI ) &gt; /=18.0 &lt; /=32.0 kg/m2 Agrees use acceptable method contraception duration study 30 day study drug administration Additional criterion may apply Is currently pregnant breastfeeding Has lifetime history menopausal hot flash Has clinically significant medical condition Has clinically significant illness 30 day prior first study drug administration Has serious infection ( eg , pneumonia septicemia ) within 3 month prior study drug administration Has vaccination 4 week prior inpatient admission Has lifetime history diabetes Additional criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Alkermes</keyword>
	<keyword>ALKS 8700</keyword>
</DOC>